Blog - Page 3597 of 5766

ThursdayMar 31, 2011 8:55 am

Millennium Pharmaceutical Becomes First Customer for Bioclinica’s (BIOC) New Product

Yesterday, Millennium Pharmacetical signed an agreement with BioClinica to become the first licensed customer for their new Enterprise Demand Aggregator (EDA) product. BioClinica and Millennium will work in conjunction in order to release the product more quickly. This will assist in Millennium's clinical trial supply planning. Millennium: The Takeda Oncology Company is a biopharm company located in Cambridge, MA. Millennium markets VELCADE, a proteasome inhibitor, as well as maintains a series of products in development. Millennium's commercial products are focused on oncology. BioClinica is a provider of clinical trial management solutions, supporting pharmaceutical and medical device development. BioClinica provides services…

ThursdayMar 31, 2011 8:46 am

Gryphon Gold Corp. (GYPH) Video Chart for Thursday, March 31, 2011

GYPH made a nice bounce after a sharp drop, but has given back some of the gains. Technical traders often expect a retrace after the initial bounce and will then look for a new higher low for the beginning of a possible upward trend. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts.php Let us hear your thoughts below:

WednesdayMar 30, 2011 1:28 pm

Sandstorm Gold Ltd. (SSL) Completes Construction at Brigus Gold Corp.’s (BRD) Black Fox Mine, Announces US$9 Million Payment to Metanor Resources (MTO)

Sandstorm Gold Ltd. (SSL), a resource based company that focuses on completing gold purchase agreements with advanced stage project companies, recently announced that Brigus Gold Corp. (BRD) has finally completed its construction of the new underground infrastructure of its Black Fox Mine. Underground ore production has begun and is expected to exceed 250 tons per day (TPD) at the end of March 2011, reaching commercial production by April 2011 and 1,100 tpd by the end of this year. The expected increase in production is partly attributed to the new 1.1-kilometer ramp leading from surface to the 235-meter level underground, which…

WednesdayMar 30, 2011 1:02 pm

ProTek Capital, Inc. (PRPM) “One to Watch”

ProTek Capital is focused on bringing together public and privately held software companies, through direct investment or outright acquisition, in order to serve shareholders the optimal return on investment possible. Having recently changed the name and focus of the Company, PRPM is now eagerly pursuing the vision of constructing a world-class technology provider. The name change followed the sale of wholly-owned subsidiary Propalms Ltd. in a share exchange valued at $2.3M and consisting of 100M shares of NX Global, Inc. Consistent with the corporate strategy, the Board also approved a dividend to the Company’s shareholders, whereby shareholders received one restricted…

WednesdayMar 30, 2011 12:43 pm

True 2 Beauty (TRTB) Adds New Product

In spite of the fact that True 2 Beauty, makers of various all-natural sexual enhancement products, are in the middle of a major production scale up, they’ve somehow managed to find time to come out with a new product. It’s a water based lubricant aptly named TNT Touch ‘N Tingle, and it’s available in his & her varieties. The line is being marketed as much to women as to men, and is said to be safe to use with latex condoms. The introduction is seen as just in time for integration with the company’s recently announced marketing campaigns. If the…

WednesdayMar 30, 2011 11:50 am

Force Fuels, Inc. (FOFU) Returns Leases and Slashes Debt

Change is in the wind for Costa Mesa, California-based Force Fuels, Inc. Over the last couple months, the Company has actively pursued partners for Joint Venture agreements and had a changing of the guard at the head of the Company. Per a recent 8-K filed with the SEC, “On March 22, 2011, the Board of Directors accepted Mr. Oscar Luppi's voluntary resignation from his positions of Chairman, President, Chief Executive Officer, and Treasurer of the Registrant. There were no disagreements or misunderstandings relating to the Registrant's operations, policies or practices between the Board and Mr. Luppi leading to his resignation.”…

WednesdayMar 30, 2011 11:45 am

Beacon Equity Research Featured Company: Advanced Cell Technology, Inc. (ACTC)

Headquartered in Santa Monica, CA, Advanced Cell Technology, Inc. is a biotechnology company that develops cellular therapies for the treatment of both rare and common diseases. Using stem cell-based technologies and other proprietary methods in the field of regenerative medicine, ACTC aims to bring patient-specific therapies from the lab to the bedside so that they can help the millions of people affected by disease every day. The company has three cellular product platforms based on ground breaking stem cell technology: Retinal Pigment Ephithelial (RPE) therapy, Myoblast stem cell therapy and the Hemangioblast (HG) platform. The company is in the process…

WednesdayMar 30, 2011 11:44 am

Beacon Equity Research Featured Company: Imperial Resources, Inc. (IPRC)

Imperial Resources, Inc. has a highly focused strategy to build a substantial portfolio of oil and gas assets through its wholly owned subsidiary, Imperial Oil & Gas Inc. The company’s access to niche, low risk oil and gas opportunities give it a unique advantage over its market competitors. With extensive industry relationships and a strong management team, the company is committed to identifying low risk opportunities which combine rapid payout and long term revenue streams. This risk-averse strategy aims to exploit high-growth projects that will deliver cash flows typical of higher risk projects, without exposure to high risk failure rates.…

WednesdayMar 30, 2011 10:19 am

Research Agreement Announced Between BG Medicine Inc. (BGMD) and Boston Scientific

BG Medicine Inc. is a life sciences company focused on the discovery, development and commercialization of novel blood-based diagnostic tests. These tests are based on biomarkers for high-value market opportunities in the healthcare industry. The company today announced that it has entered into a research collaboration agreement with Boston Scientific Corporation, a leading medical device manufacturer. The focus of the agreement is to study the role of BG Medicine's lead product – the Galectin-3 assay for chronic heart failure – as an aid in patient screening for cardiac-resynchronization therapy (CRT) using patient data from the MADIT-CRT study. The MADIT-CRT study…

WednesdayMar 30, 2011 10:17 am

Gunpowder Gold Corp. (GUNP) Updates Arizona Exploration Program

Gunpowder Gold Corp. issued an update on its exploration and development program in the United States. The company is actively looking for areas that are prospective for gold and other precious metals. Gunpowder Gold has started the Phase One exploration program at the Dome Rock property located in La Paz County, Arizona. The company expects to have the first results from that program in April 2011. Phase One involves several different processes to determine the mineral content of the property. Gunpowder Gold is conducting stream sediment sampling on different washes near the claims area, and will test the sediment samples…

Site Search

Company Search